.

Coherus Biosciences reported $-50150000 in Pre-Tax Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -33.57M 79M
Alnylam Pharmaceuticals ALNY:US $ -274.67M 35.32M
Amarin AMRN:US $ -64.8M 36.45M
Biogen BIIB:US $ 874.8M 28.6M
Biomarin Pharmaceutical BMRN:US $ 34.85M 8.66M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Coherus Biosciences CHRS:US $ -50.15M 45.93M
Fujifilm 4901:JP Y 55195M 1989M
LG Chem 051910:KS KW 1023562M 511827M
Ptc Therapeutics PTCT:US $ -148.7M 26.8M
Revance Therapeutics RVNC:US $ -61.44M 2.91M
Sarepta Therapeutics SRPT:US $ -228.09M 123.95M
Teva Pharmaceutical TEVA:IT -1160000000 189M
Xencor XNCR:US $ -33.98M 57.57M